Determination of Pump Flow Rate During Cardiopulmonary Bypass in Obese Patients Avoiding Hemodilution

2009 ◽  
Vol 24 (3) ◽  
pp. 245-249 ◽  
Author(s):  
Luisa Santambrogio ◽  
Cristian Leva ◽  
Giorgio Musazzi ◽  
Piergiorgio Bruno ◽  
Andrea Vailati ◽  
...  
2007 ◽  
Vol 24 (Supplement 39) ◽  
pp. 53
Author(s):  
R. Valero ◽  
P. Santos-Cidón ◽  
M. Net ◽  
L I. Capdevila ◽  
J C. García-Valdecasas

ASAIO Journal ◽  
1993 ◽  
Vol 39 (2) ◽  
pp. 126-131
Author(s):  
Ryuji Tominaga ◽  
Kazuhiro Kurisu ◽  
Fumio Fukumura ◽  
Atsuhiro Nakashima ◽  
Manabu Hisahara ◽  
...  

1990 ◽  
Vol 73 (3A) ◽  
pp. NA-NA
Author(s):  
F H Kem ◽  
W J Greeley ◽  
R M Ungerleider ◽  
T J Quill ◽  
B. Baldwin ◽  
...  

Perfusion ◽  
1986 ◽  
Vol 1 (4) ◽  
pp. 245-253 ◽  
Author(s):  
RT Mathie ◽  
JB Desai ◽  
KM Taylor

Hepatic blood flow was investigated in two groups of eight anaesthetized dogs during and after one hour of either pulsatile or non-pulsatile cardiopulmonary bypass (CPB). Mean perfusion pressure was maintained at 60 mmHg. Hepatic arterial (HA) and portal venous (PV) blood flows were measured using electromagnetic flow probes, and hepatic O 2 consumption determined. The results demonstrate that: (a) pulsatile CPB reduces peripheral vascular resistance during and after perfusion, and more effectively preserves pump flow rate and cardiac output than non-pulsatile CPB; (b) total liver blood flow is sustained more effectively by pulsatile CPB than by non-pulsatile CPB due to relative preservation of both HA and PV flows; (c) hepatic O2 consumption is only marginally better preserved during and after pulsatile CPB than with non-pulsatile perfusion. We conclude that: (a) pulsatile CPB tends to maintain hepatic blood flow through a relative reduction in HA vascular resistance and an improvement in PV flow produced passively by a greater pump flow rate; (b) pulsatile CPB less effectively benefits hepatic O2 consumption because of poor O2 uptake from the hepatic PV blood supply.


1997 ◽  
Vol 11 (4) ◽  
pp. 415-419 ◽  
Author(s):  
David J. Cook ◽  
Jacqueline A. Proper ◽  
Thomas A. Orszulak ◽  
Richard C. Daly ◽  
William C. Oliver

ASAIO Journal ◽  
1993 ◽  
Vol 39 (2) ◽  
pp. 126-131 ◽  
Author(s):  
Ryuji Tominaga ◽  
Kazuhiro Kurisu ◽  
Fumio Fukumura ◽  
Atsuhiro Nakashima ◽  
Manabu Hisahara ◽  
...  

1997 ◽  
Vol 114 (4) ◽  
pp. 568-577 ◽  
Author(s):  
Gabriel Chow ◽  
Idris G. Roberts ◽  
A.David Edwards ◽  
Adrian Lloyd-Thomas ◽  
Angie Wade ◽  
...  

2018 ◽  
Vol 46 (4) ◽  
pp. 279-285 ◽  
Author(s):  
Maxime Leclerc ◽  
Clémence Bechade ◽  
Patrick Henri ◽  
Elie Zagdoun ◽  
Erick Cardineau ◽  
...  

We conducted a prospective study to assess the impact of the blood pump flow rate (BFR) on the dialysis dose with a low dialysate flow rate. Seventeen patients were observed for 3 short hemodialysis sessions in which only the BFR was altered (300,350 and 450 mL/min). Kt/V urea increased from 0.54 ± 0.10 to 0.58 ± 0.08 and 0.61 ± 0.09 for BFR of 300, 400 and 450 mL/min. For the same BFR variations, the reduction ratio (RR) of β2microglobulin increased from 0.40 ± 0.07 to 0.45 ± 0.06 and 0.48 ± 0.06 and the RR phosphorus increased from 0.46 ± 0.1 to 0.48 ± 0.08 and 0.49 ± 0.07. In bivariate analysis accounting for repeated observations, an increasing BFR resulted in an increase in spKt/V (0.048 per 100 mL/min increment in BPR [p < 0.05, 95% CI (0.03–0.06)]) and an increase in the RR β2m (5% per 100 mL/min increment in BPR [p < 0.05, 95% CI (0.03–0.07)]). An increasing BFR with low dialysate improves the removal of urea and β2m but with a potentially limited clinical impact.


Sign in / Sign up

Export Citation Format

Share Document